These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 15051384
1. Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone. Balasuriya UB, Dobbe JC, Heidner HW, Smalley VL, Navarrette A, Snijder EJ, MacLachlan NJ. Virology; 2004 Apr 10; 321(2):235-46. PubMed ID: 15051384 [Abstract] [Full Text] [Related]
2. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. Balasuriya UB, Patton JF, Rossitto PV, Timoney PJ, McCollum WH, MacLachlan NJ. Virology; 1997 May 26; 232(1):114-28. PubMed ID: 9185595 [Abstract] [Full Text] [Related]
3. Identification of an additional neutralization determinant of equine arteritis virus. Zhang J, Timoney PJ, Maclachlan NJ, Balasuriya UB. Virus Res; 2008 Dec 26; 138(1-2):150-3. PubMed ID: 18851997 [Abstract] [Full Text] [Related]
4. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus. Balasuriya UB, Maclachlan NJ, De Vries AA, Rossitto PV, Rottier PJ. Virology; 1995 Mar 10; 207(2):518-27. PubMed ID: 7533965 [Abstract] [Full Text] [Related]
5. Evaluation of neutralization patterns of the five unique Argentine equine arteritis virus field strains reported. Echeverría MG, Díaz S, Metz GE, Serena MS, Panei CJ, Nosetto E. Rev Argent Microbiol; 2010 Mar 10; 42(1):11-7. PubMed ID: 20461287 [Abstract] [Full Text] [Related]
6. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Balasuriya UB, Timoney PJ, McCollum WH, MacLachlan NJ. Virology; 1995 Dec 20; 214(2):690-7. PubMed ID: 8553578 [Abstract] [Full Text] [Related]
7. Comparison of equine arteritis virus isolates using neutralizing monoclonal antibodies and identification of sequence changes in GL associated with neutralization resistance. Glaser AL, de Vries AA, Dubovi EJ. J Gen Virol; 1995 Sep 20; 76 ( Pt 9)():2223-33. PubMed ID: 7561759 [Abstract] [Full Text] [Related]
8. Chimeric viruses containing the N-terminal ectodomains of GP5 and M proteins of porcine reproductive and respiratory syndrome virus do not change the cellular tropism of equine arteritis virus. Lu Z, Zhang J, Huang CM, Go YY, Faaberg KS, Rowland RR, Timoney PJ, Balasuriya UB. Virology; 2012 Oct 10; 432(1):99-109. PubMed ID: 22739441 [Abstract] [Full Text] [Related]
9. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Plagemann PG, Rowland RR, Faaberg KS. Arch Virol; 2002 Dec 10; 147(12):2327-47. PubMed ID: 12491101 [Abstract] [Full Text] [Related]
10. Genomic and antigenic variations of porcine reproductive and respiratory syndrome virus major envelope GP5 glycoprotein. Pirzadeh B, Gagnon CA, Dea S. Can J Vet Res; 1998 Jul 10; 62(3):170-7. PubMed ID: 9684045 [Abstract] [Full Text] [Related]
11. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus. Plagemann PG. Vet Immunol Immunopathol; 2004 Dec 08; 102(3):263-75. PubMed ID: 15507310 [Abstract] [Full Text] [Related]
12. A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies. Balasuriya UB, Rossitto PV, DeMaula CD, MacLachlan NJ. J Gen Virol; 1993 Nov 08; 74 ( Pt 11)():2525-9. PubMed ID: 7504076 [Abstract] [Full Text] [Related]
13. Construction of chimeric arteriviruses reveals that the ectodomain of the major glycoprotein is not the main determinant of equine arteritis virus tropism in cell culture. Dobbe JC, van der Meer Y, Spaan WJ, Snijder EJ. Virology; 2001 Sep 30; 288(2):283-94. PubMed ID: 11601900 [Abstract] [Full Text] [Related]
14. Recombinant equine arteritis virus as an expression vector. de Vries AA, Glaser AL, Raamsman MJ, Rottier PJ. Virology; 2001 Jun 05; 284(2):259-76. PubMed ID: 11384225 [Abstract] [Full Text] [Related]
15. Amino acid substitutions in the structural or nonstructural proteins of a vaccine strain of equine arteritis virus are associated with its attenuation. Zhang J, Go YY, MacLachlan NJ, Meade BJ, Timoney PJ, Balasuriya UB. Virology; 2008 Sep 01; 378(2):355-62. PubMed ID: 18619638 [Abstract] [Full Text] [Related]
16. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Gromowski GD, Barrett AD. Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070 [Abstract] [Full Text] [Related]
17. Comparative analysis of ORF5 nucleotide sequences and amino acid sequences of the GP5 protein of equine arteritis virus (EAV) detected in the semen of stallions from Eastern Poland. Surma-Kurusiewicz K, Winiarczyk S, Adaszek Ł. Res Vet Sci; 2013 Apr 30; 94(2):361-7. PubMed ID: 23116636 [Abstract] [Full Text] [Related]
18. Serologic and molecular characterization of an abortigenic strain of equine arteritis virus isolated from infective frozen semen and an aborted equine fetus. Balasuriya UB, Evermann JF, Hedges JF, McKeirnan AJ, Mitten JQ, Beyer JC, McCollum WH, Timoney PJ, MacLachlan NJ. J Am Vet Med Assoc; 1998 Dec 01; 213(11):1586-9, 1570. PubMed ID: 9838958 [Abstract] [Full Text] [Related]
19. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Hiramatsu K, Tadano M, Men R, Lai CJ. Virology; 1996 Oct 15; 224(2):437-45. PubMed ID: 8874504 [Abstract] [Full Text] [Related]
20. Large envelope glycoprotein and nucleocapsid protein of equine arteritis virus (EAV) induce an immune response in Balb/c mice by DNA vaccination; strategy for developing a DNA-vaccine against EAV-infection. Tobiasch E, Kehm R, Bahr U, Tidona CA, Jakob NJ, Handermann M, Darai G, Giese M. Virus Genes; 2001 Mar 15; 22(2):187-99. PubMed ID: 11324756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]